
Perspective Therapeutics, Inc.
Perspective Therapeutics, Inc.(CATX)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
catx · 股价预测 · 11 位分析师(近3月)· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 11 位华尔街分析师
Buy
11 位分析师
共识
评级分布
12 个月目标价
High
$16.00
Consensus
$13.33
+355.7% upside
Low
$12.00
Median: $12 · Last Close: $2.92
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$13.33
355.7% upside
High Target
$16
447.0%
Low Target
$12
310.3%
Current Price
$2.92
as of today
Based on analyst price targets, the CATX stock price prediction for the next 12 months ranges from $12 to $16. The consensus CATX price forecast of $13.33 implies 355.7% upside from the current price of $2.92.
短期股价预测
Bear算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $2.78 | ↓ 5.00% |
1-day model range: $2.75–$2.81. Peak: $2.81 (-5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CATX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-05 | BTIG | Maintains | Buy→Buy |
| 2026-05-05 | Wedbush | Maintains | Outperform→Outperform |
| 2026-04-20 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-18 | UBS | Maintains | Buy→Buy |
| 2026-03-18 | B. Riley Securities | Maintains | Buy→Buy |
| 2026-03-18 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-17 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-03-17 | BTIG | Maintains | Buy→Buy |
| 2026-01-30 | Wedbush | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Perspective Therapeutics, Inc. (CATX) stock. Of the recent 43 rating actions, 0 were upgrades and 2 were downgrades. 11 analysts currently cover CATX.
分析师推荐趋势
CATX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 2 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$0M
↓ 97.4% YoY
Revenue Next Year
$0M
↑ 12.7% YoY
EPS This Year
$-1.11
EPS Next Year
$-1.11
↑ 0.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast CATX EPS of $-1.11 for the current fiscal year, based on estimates from 10 analysts. The CATX revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CATX 股价预测由两类独立数据源支撑:来自 11 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。CATX 的共识目标价为 $13.33(+355.7% 上行空间),分析师共识为 Buy。
CATX 的短期预测(明日)为 $2.78(-5.00%)。
Perspective Therapeutics, Inc. 在 AMEX 上市,代码 CATX。CATX 在 2027 年的整体展望偏积极,在覆盖分析师中约 82% 对应 Buy 共识。
常见问题
CATX 预测 · 8 个问题根据 11 位华尔街分析师,CATX 的 12 个月平均目标价为 $13.33,最高 $16.00、最低 $12.00。若有图表,中位目标价可在上方查看。相对当前价 $2.92,隐含约 +355.7% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.